1. Home
  2. BCO vs RLAY Comparison

BCO vs RLAY Comparison

Compare BCO & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brinks Company (The)

BCO

Brinks Company (The)

HOLD

Current Price

$109.28

Market Cap

4.8B

ML Signal

HOLD

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$19.06

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCO
RLAY
Founded
1859
2015
Country
United States
United States
Employees
125
N/A
Industry
Oil Refining/Marketing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
4.1B
IPO Year
2010
2020

Fundamental Metrics

Financial Performance
Metric
BCO
RLAY
Price
$109.28
$19.06
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
10
Target Price
$154.00
$19.50
AVG Volume (30 Days)
334.3K
2.7M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
0.95%
N/A
EPS Growth
29.20
31.78
EPS
1.84
N/A
Revenue
$3,562,300,000.00
$15,355,000.00
Revenue This Year
$7.22
N/A
Revenue Next Year
$5.92
$324.03
P/E Ratio
$60.86
N/A
Revenue Growth
N/A
53.44
52 Week Low
$91.05
$4.05
52 Week High
$136.37
$21.27

Technical Indicators

Market Signals
Indicator
BCO
RLAY
Relative Strength Index (RSI) 52.20 48.89
Support Level $108.20 $18.00
Resistance Level $117.18 $20.82
Average True Range (ATR) 3.03 0.70
MACD 0.23 -0.06
Stochastic Oscillator 80.59 38.43

Price Performance

Historical Comparison
BCO
RLAY

About BCO Brinks Company (The)

The Brink's Co is a provider of secure logistics and security solutions for cash and other valuables. Its segments include: North America segment includes operations in the U.S. and Canada, including the Brink's Global Services (BGS) line of business; Latin America segment consists operations in Latin American countries where it has an ownership interest, including the BGS line of business; Europe segment includes total operations in European countries that provide services outside of the BGS line of business; and Rest of World segment consists operations in the Middle East, Africa and Asia. It also includes total operations in European countries that provide BGS services and BGS activity in Latin American countries. It derives maximum revenue from the North America segment.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

Share on Social Networks: